These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21817161)

  • 1. CD34+ autologous human stem cells in treating refractory angina.
    Perin EC; Willerson JT
    Circ Res; 2011 Aug; 109(4):351-2. PubMed ID: 21817161
    [No Abstract]   [Full Text] [Related]  

  • 2. Intramyocardial, autologous CD34+ cell therapy for refractory angina.
    Losordo DW; Henry TD; Davidson C; Sup Lee J; Costa MA; Bass T; Mendelsohn F; Fortuin FD; Pepine CJ; Traverse JH; Amrani D; Ewenstein BM; Riedel N; Story K; Barker K; Povsic TJ; Harrington RA; Schatz RA;
    Circ Res; 2011 Aug; 109(4):428-36. PubMed ID: 21737787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study.
    Lasala GP; Silva JA; Kusnick BA; Minguell JJ
    Cardiovasc Revasc Med; 2011; 12(1):29-34. PubMed ID: 21241969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
    Povsic TJ; Henry TD; Traverse JH; Fortuin FD; Schaer GL; Kereiakes DJ; Schatz RA; Zeiher AM; White CJ; Stewart DJ; Jolicoeur EM; Bass T; Henderson DA; Dignacco P; Gu Z; Al-Khalidi HR; Junge C; Nada A; Hunt AS; Losordo DW;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1576-85. PubMed ID: 27491607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials.
    Velagapudi P; Turagam M; Kolte D; Khera S; Hyder O; Gordon P; Aronow HD; Leopold J; Abbott JD
    Cardiovasc Revasc Med; 2019 Mar; 20(3):215-219. PubMed ID: 29908826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease.
    Weber A; Pedrosa I; Kawamoto A; Himes N; Munasinghe J; Asahara T; Rofsky NM; Losordo DW
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):137-43. PubMed ID: 15200992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction.
    Iwasaki H; Kawamoto A; Ishikawa M; Oyamada A; Nakamori S; Nishimura H; Sadamoto K; Horii M; Matsumoto T; Murasawa S; Shibata T; Suehiro S; Asahara T
    Circulation; 2006 Mar; 113(10):1311-25. PubMed ID: 16534028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
    Kawamoto A; Asahara T
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis.
    Hashimoto N; Iwasaki T; Sekiguchi M; Takatsuka H; Okamoto T; Hashimoto T; Sano H
    Bone Marrow Transplant; 2004 Apr; 33(8):863-6. PubMed ID: 14755313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration.
    Kwon SM; Suzuki T; Kawamoto A; Ii M; Eguchi M; Akimaru H; Wada M; Matsumoto T; Masuda H; Nakagawa Y; Nishimura H; Kawai K; Takaki S; Asahara T
    Circ Res; 2009 Apr; 104(8):969-77. PubMed ID: 19325148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts.
    Sekine H; Shimizu T; Hobo K; Sekiya S; Yang J; Yamato M; Kurosawa H; Kobayashi E; Okano T
    Circulation; 2008 Sep; 118(14 Suppl):S145-52. PubMed ID: 18824746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new option for the "no-option" patient with refractory angina?
    Henry TD
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):395-7. PubMed ID: 19681118
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mobilization of stem cells in cardiovascular disease. Improvement of vascularization, cardiac function and arrhythmias].
    Nikol S; Kuhlmann M
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():190-2. PubMed ID: 16802552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intramyocardial injection of autologous bone-marrow stem cells in a 74-year-old man with untreatable angina pectoris and demonstrated myocardial ischaemia].
    Beeres SL; Bax JJ; Stokkel MP; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    Ned Tijdschr Geneeskd; 2006 Jul; 150(27):1523-7. PubMed ID: 16892617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous CD34
    Henry TD; Schaer GL; Traverse JH; Povsic TJ; Davidson C; Lee JS; Costa MA; Bass T; Mendelsohn F; Fortuin FD; Pepine CJ; Patel AN; Riedel N; Junge C; Hunt A; Kereiakes DJ; White C; Harrington RA; Schatz RA; Losordo DW;
    Cell Transplant; 2016; 25(9):1701-1711. PubMed ID: 27151378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.
    Kocher AA; Schuster MD; Szabolcs MJ; Takuma S; Burkhoff D; Wang J; Homma S; Edwards NM; Itescu S
    Nat Med; 2001 Apr; 7(4):430-6. PubMed ID: 11283669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina.
    Vicario J; Campo C; Piva J; Faccio F; Gerardo L; Becker C; Ortega H; Pierini A; Lofeudo C; Novero R; Baliño NP; Monti A; Benech R; Dallo M; Pfeiffer H
    Cardiovasc Revasc Med; 2005; 6(3):99-107. PubMed ID: 16275605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of myocardial injury in the pericardial fluid of patients undergoing heart surgery.
    Fernández AL; García-Bengochea JB; Alvarez J; González Juanatey JR
    Interact Cardiovasc Thorac Surg; 2008 May; 7(3):373-6; discussion 376-7. PubMed ID: 18258649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial progenitor cells as a therapeutic option in peripheral arterial disease.
    Devanesan AJ; Laughlan KA; Girn HR; Homer-Vanniasinkam S
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):475-81. PubMed ID: 19560945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Slauson cutoff and peri-operative risk for abdominal vascular surgery.
    Butman SM
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):142-3. PubMed ID: 21181974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.